- Clinical Trials
- April 2024
- 60 Pages
Global
From €1911EUR$2,000USD£1,626GBP
- Report
- February 2024
- 175 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- February 2024
- 250 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- February 2024
- 250 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- January 2024
- 200 Pages
Global
From €4778EUR$5,000USD£4,066GBP
- Report
- March 2024
- 196 Pages
Global
From €3224EUR$3,374USD£2,744GBP
€3583EUR$3,749USD£3,048GBP
- Report
- August 2023
- 250 Pages
Global
From €2380EUR$2,490USD£2,025GBP
- Report
- October 2023
- 150 Pages
Global
From €4635EUR$4,850USD£3,944GBP
- Report
- May 2024
- 133 Pages
Global
From €6211EUR$6,499USD£5,284GBP
- Report
- May 2024
- 135 Pages
Global
From €6211EUR$6,499USD£5,284GBP
- Report
- May 2024
- 150 Pages
Global
From €5352EUR$5,600USD£4,553GBP
- Report
- November 2023
- 144 Pages
Global
From €2388EUR$2,499USD£2,032GBP
- Clinical Trials
- April 2024
- 250 Pages
Global
From €2867EUR$3,000USD£2,439GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1433EUR$1,500USD£1,220GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1911EUR$2,000USD£1,626GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1911EUR$2,000USD£1,626GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1911EUR$2,000USD£1,626GBP
- Clinical Trials
- February 2024
- 180 Pages
Global
From €2867EUR$3,000USD£2,439GBP
- Report
- October 2023
- 181 Pages
Global
From €4683EUR$4,900USD£3,984GBP
- Report
- June 2023
- 118 Pages
Global
From €4300EUR$4,500USD£3,659GBP
The Arthritis Drug market is a subset of the Immune Disorders Drugs market, which includes treatments for a variety of conditions related to the immune system. Arthritis drugs are used to treat the inflammation and pain associated with arthritis, a condition that affects the joints and surrounding tissues. These drugs can be divided into two main categories: non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs). NSAIDs are used to reduce inflammation and pain, while DMARDs are used to slow the progression of the disease.
The Arthritis Drug market is highly competitive, with a number of large pharmaceutical companies offering a variety of treatments. Some of the major players in the market include Pfizer, Merck, AbbVie, Johnson & Johnson, and Novartis. Show Less Read more